9 stories
All topics
An mRNA-based malaria vaccine developed by Oxford and BioNTech has demonstrated 95% efficacy in a Phase 3 trial involving 22,000 children across six African nations, far surpassing existing vaccines and offering hope for eliminating the disease.
A study of over 246,000 adults with heart disease found that shingles vaccination was associated with a 46% reduction in major cardiac events and a 66% reduction in all-cause mortality within one year.
Research shows the shingles vaccine may double as a heart protector, cutting major cardiac events by 46% and deaths by 66% within a year in people already at high cardiovascular risk.
A single-dose vaccine targeting a conserved region of the influenza virus provided 88% protection across all strains for at least three years in a 25,000-person trial.
A major new study has identified three familiar medicines — including the shingles vaccine — that could take on an unexpected new role in the fight against Alzheimer's disease, offering hope to the millions of families affected worldwide.
The groundbreaking malaria vaccine has now been administered to 10 million children across Africa, dramatically reducing deaths from one of humanity oldest killers.
A study of nearly 14 million children in England reveals that Covid infection carries a substantially higher risk of heart complications than vaccination.
Scientists at Melbourne's Doherty Institute used mRNA technology to force HIV out of hiding in white blood cells, a critical step toward a cure. The technique encases HIV in a "fat bubble" nanoparticle that reveals the virus to the immune system.
Researchers at the University of Florida developed an mRNA cancer vaccine that supercharges the immune system to recognize and attack cancer cells, paving the way for a potential universal cancer treatment.
